Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Collectively declared rate

4.89%

Threshold

Crossed upwards

Timeline

Published

25.11.2010

Transaction

17.11.2010

Transfer date

17.11.2010

Voting rights breakdown

Voting rights acquired4.89%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBABO00028

Beneficial owner

Jonathan J. Fleming

Declared address

Jonathan J. Fleming, Newton MA 02462

OBP Management III L.P. is the General Partner of - Oxford Bioscience Partners III L.P. - Oxford Bioscience Partners (Adjunct) III L.P. - mRNA Fund L.P. OBP Management (Bermuda) III L.P. is the General Partner of - Oxford Bioscience Partners (Bermuda) III L.P.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open